Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Profilin 1 pseudogene 9 (PFN1P9) is a non-functional, non-coding pseudogene with sequence similarity to the PFN1 gene, the latter of which encodes the actin-binding protein profilin-1. PFN1P9 has no known biological function, no role in disease, and is not a therapeutic target. All relevant functional and clinical information pertains to PFN1, not PFN1P9[1][7][8][9]. Key clarification: If you seek information on the actual therapeutic/protein target, you should refer to “profilin 1” (PFN1), not PFN1P9. Profilin 1 is a cytoskeletal regulator with roles in actin dynamics, cell survival, and cancer biology, but PFN1P9 itself is not a relevant drug target, receptor, or disease-related molecule[1][2][4].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Profilin 1 pseudogene 9 (PFN1P9).